DRUŠTVO SA OGRANIČENOM ODGOVORNOŠĆU "MEGAPHARM " CETINJE
Total revenue · 2017–2017
185,268€2017.
| Year | Total revenue | Change |
|---|---|---|
| 185,268€ | — |
Click or tap a year to see its figures; drag across the chart to preview. Source: Tax Administration (IRMS) income statements.
Companies in the same activity or sector with a third to three times this company's revenue. The button next to one adds it to the comparison.
Event · 31 Jan 2026
Account blocked
26.8k€
Event · 12 Jun 2019
Court activity
Event · 2017
First year in BizStats data
Event · 2017
Peak revenue
185.3k€
Event · 12 Jan 2017
Registered
Društvo sa ograničenom odgovornošću
Profit margin
1.2%median 0.9%
30% above the median
20172017
Revenue per employee
46,317€median 34,305€
35% above the median
20172017
Median of 3,964 companies in the sector that filed for 2017.
Source and methodology: Public financial filings, CRPS, CBCG, and eKatastar where available. Revenue, profit, employees, and payroll costs come from public financial filings; average gross pay and revenue per employee are derived metrics. Rankings are calculated by total revenue for the latest visible year.
Latest filing year: 2017 · Filing listing (IRMS): 19 May 2026
Source data as of: CBCG 30 Sept 2026 · Tax Administration 31 Mar 2025 – 30 Sept 2025 · IRMS 19 May 2026
Source: Central Bank of Montenegro, CRTR and monthly blocked-account snapshots.
This company's list of open accounts is not available on BizStats at the moment. Check it in the Central Bank's official CRTR registry.
Source: Central Bank of Montenegro, CRTR and monthly blocked-account snapshots.
Check in CRTR registryOfficial CBCG account registry. Enter PIB 03118924 in the search.
Court records mention this company. Check its role and the case details before treating this as a risk signal; this is not a formal credit rating.As of 30 Jun 2026
| Case | Matched as | Role | Opposite party | Status | Court source | |
|---|---|---|---|---|---|---|
| 2019-06-1212:00 | MAL br. 65/19Privredni sud Crne GoreJudge: HASANAGIĆ SENADA | MEGAPHARMexact name | Defendant | S PRESS | Zakazano | Court source |
| 2019-05-1512:30 | MAL br. 65/19Privredni sud Crne GoreJudge: HASANAGIĆ SENADA | MEGAPHARMexact name | Defendant | S PRESS | Zakazano | Court source |
| 2019-05-1412:30 | MAL br. 65/19Privredni sud Crne GoreJudge: HASANAGIĆ SENADA | MEGAPHARMexact name | Defendant | S PRESS | Zakazano | Court source |
| 2019-04-2308:30 | MAL br. 65/19Privredni sud Crne GoreJudge: HASANAGIĆ SENADA | MEGAPHARMexact name | Defendant | S PRESS | Odloženo-neodržano | Court source |
| 2019-04-0811:30 | MAL br. 65/19Privredni sud Crne GoreJudge: HASANAGIĆ SENADA | MEGAPHARMexact name | Defendant | S PRESS | Zakazano | Court source |
Data from the sudovi.me portal, fetched 30 Jun 2026. Upcoming hearings and statuses are shown as they were published then.
Source: the public sudovi.me court portal. A hearing is linked to the company only when the party name matches its registered name (differing at most in legal form or seat) and fits no other company; a decision only when its text prints the company's PIB or registration number, with the role read from the passage naming it. Published decisions are an approximation of completed proceedings, not a complete PRIS status.
Source links open the sudovi.me search, not the case itself: copy the case number and enter it in the search to check the record. Decision search
CRPS does not publish PIBs for company owners, so the number of companies this company owns cannot be determined reliably.
Source: CRPS persons in company and company shares, fetched 2026-06-15. Direct registry relationships only.
People and roles in the current CRPS register. Historical financial filings do not establish current authorization.
Loading CRPS register…
Persons listed as “Odgovorno lice” in financial filings, by reporting year. These are historical filing records, not confirmation of current CRPS authorization. The preparer is not shown.
IRMS financial filings: years shown are reporting years, not appointment or authorization periods. Original names and source reports are preserved below.